Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome

PHASE4RecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

December 31, 2026

Conditions
Metabolic Syndrome
Interventions
DRUG

Semaglutide, Empagliflozin

subcutaneous Semaglutide (GLP-1RA) 1 mg once a 7 day with oral Empagliflozin (SGLT-2i) 25 mg once a day

PROCEDURE

Minigastric bypass

Endovideososcopic techniques with the intraperitoneal using of synthetic/biological materials. MGB is performed to reduce the absorption surface of the gastrointestinal tract by shunting the greater part of the stomach, the duodenum and the initial section of the small intestine, which reduces the absorption of food and leads to a decrease in the production of gastrointestinal hormones.

DIETARY_SUPPLEMENT

Analimentary detoxication

very-low-calorie-restriction diet ('Analimentary-detoxication') including \<100 kcal/day with fat-free vegetables (tomato/cucumber) and salt intake (5-6 g/day), optimum physical activity, and sexual self-restraint.

BEHAVIORAL

Ramadan fast's weight loss

"The participants adhered to fasting on RF season. They strictly adhered to two principles of nutrition during RF: 1) no blood, no smell of fat which means don't eat meat and don't eat fatty foods; 2) the 'Sehri time' (a meal eaten before dawn) included just 1.5-2.0 glass of water and fruits of 80-100 gr (apple, dates, and persimmon). Indeed, the patients followed a diet in which they ate one meal a day - participants have a meal during 'Iftar time' (a meal eaten after sunset)."

Trial Locations (1)

010000

RECRUITING

Kuat Pernekulovich Oshakbayev, Astana

All Listed Sponsors
collaborator

Ministry of Science and Higher Education of the Republic of Kazakhstan

OTHER_GOV

collaborator

Nazarbayev University School of Medicine

UNKNOWN

collaborator

Nazarbayev University

OTHER

collaborator

Astana Medical University

OTHER

lead

University Medical Center, Kazakhstan

OTHER